Risk of Contralateral Breast Cancer in Women With and Without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women With Very Early-Onset (<36 Years) Breast Cancer

Cancers - Switzerland
doi 10.3390/cancers12020378
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Mutational Analysis of BRCA1 and BRCA2 Genes in Spanish Women With Early-Onset Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2000English

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Contralateral Breast Cancer Risk and the Selection of Contralateral Prophylactic Mastectomy Among Women With Unilateral Breast Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Analysis of the Pathogenic Variants of BRCA1 and BRCA2 Using Next-Generation Sequencing in Women With Familial Breast Cancer: A Case–control Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Mutational Analysis of BRCA1 and BRCA2 Genes in Women With Familial Breast Cancer From Different Regions of Colombia

Hereditary Cancer in Clinical Practice
OncologyGenetics
2019English

Founder BRCA1/BRCA2/PALB2 Pathogenic Variants in French-Canadian Breast Cancer Cases and Controls

Scientific Reports
Multidisciplinary
2020English

Breast Cancer in Young Women: Prevalence of LOH at P53, BRCA1 and BRCA2

Breast Cancer Research
Cancer ResearchOncology
2000English

Early Onset of Breast Cancer in British Black Women

British Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy